NEW YORK, April 05, 2018 -- The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the United States District Court for the District of New Jersey on behalf of investors who purchased Johnson & Johnson ("Johnson & Johnson") (NYSE:JNJ) securities between February 22, 2013 and February 7, 2018.
Click here to learn about the case: http://www.wongesq.com/pslra-c/johnson-johnson?wire=3. There is no cost or obligation to you.
According to the complaint, throughout the Class Period, the Company issued materially false and misleading statements and/or failed to disclose that: (1) Johnson & Johnson has known for decades that its talc products include asbestos fibers and that the exposure to those fibers can cause ovarian cancer and mesothelioma; and (2) as a result, Defendants' public statements were materially false and misleading at all relevant times.
If you suffered a loss in Johnson & Johnson you have until April 9, 2018 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff. To obtain additional information, contact Vincent Wong, Esq. either via email [email protected], by telephone at 212.425.1140, or visit http://www.wongesq.com/pslra-c/johnson-johnson?wire=3.
Vincent Wong, Esq. is an experienced attorney that has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
Vincent Wong, Esq.
39 East Broadway
Suite 304
New York, NY 10002
Tel. 212.425.1140
Fax. 866.699.3880
E-Mail: [email protected]


Amazon Explores AI Content Marketplace With Media Publishers
Samsung Electronics Sees Sustained AI-Driven Demand for Memory Chips Into Next Year
Moderna Stock Drops After FDA Declines Review of mRNA Flu Vaccine
Samsung Electronics Shares Jump on HBM4 Mass Production Report
Cloudflare Forecasts Strong Revenue Growth as AI Fuels Cloud Services Demand
Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal
SMIC Shares Slide Despite Strong AI-Driven Earnings as Margin Pressure Looms
Taiwan Says Moving 40% of Semiconductor Production to the U.S. Is Impossible
Lyft Shares Slide After Weak Q1 Profit Forecast and Surprise 2025 Operating Loss
Salesforce Workforce Reduction Affects Fewer Than 1,000 Roles Amid Ongoing Restructuring
xAI Co-Founder Jimmy Ba Departs as Elon Musk’s AI Startup Faces Turbulence
Canadian Airlines Suspend Cuba Flights Amid Jet Fuel Shortage and U.S. Sanctions
Macquarie Group Shares Jump as Third-Quarter Trading Conditions Improve Across Key Units
Russia Signals Further Restrictions on Telegram Amid Ongoing Regulatory Disputes
Petrobras Posts Record Oil Exports as Production Surge Fuels Global Expansion
Alphabet Plans Rare 100-Year Sterling Bond to Fund AI Expansion
AST SpaceMobile Joins MSCI ACWI Index as Largest New Addition, Boosting Market Visibility 



